RCEL and AVH Related Headlines
Go Back- AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
- AVITA Medical adds healthcare executive to board, chairman retires
- AVITA Medical Announces Changes to its Board of Directors
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA® Medical Reports Third Quarter 2025 Financial Results
- Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
- AVITA Medical to Announce Third Quarter 2025 Financial Results
- AVITA Medical Welcomes Support for RECELL® in Burns in Australia
- AVITA Medical names board chairman as interim CEO
- AVITA Medical Announces CEO Transition
- CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
- AVITA Medical receives CE mark for RECELL GO device in Europe
- AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
- Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
- AVITA Medical Announces September Investor Conference Participation
- AVITA Medical Successfully Completes Australian Equity Raise
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
- AVITA Medical names Michael Tarnoff to board, Cary Vance as chair
- AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
- AVITA Medical to Announce Second Quarter 2025 Financial Results
RCEL and AVH Related Press Releases
Go Back- AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
- AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
- AVITA Medical Announces Changes to its Board of Directors
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA® Medical Reports Third Quarter 2025 Financial Results
- Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
- AVITA Medical to Announce Third Quarter 2025 Financial Results
- AVITA Medical Welcomes Support for RECELL® in Burns in Australia
- AVITA Medical Announces CEO Transition
- CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
- AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
- Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
- AVITA Medical Announces September Investor Conference Participation
- AVITA Medical Successfully Completes Australian Equity Raise
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
- AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
- AVITA Medical to Announce Second Quarter 2025 Financial Results
